Nxera Pharma is changing its board of directors by adding two new external directors

From GlobeNewswire: 2025-02-14 01:35:00

Nxera Pharma Co., Ltd. announces changes to its Board of Directors, with Ms. Naoko Shimura and Ms. Nicola Rabson nominated as new External Directors, while Mr. Shinichi Tamura, Mr. Tomohiro Tohyama, and Mr. Kuniaki Kaga will retire. The appointments are pending ratification at the upcoming General Meeting of Shareholders on March 26, 2025. Both new nominees bring extensive legal expertise and experience to the Board, with Shimura specializing in corporate legal affairs and Rabson in employment law. The Company expects their guidance to strengthen management oversight and governance. Additionally, Nxera Pharma is focused on developing specialty medicines to address unmet patient needs globally.

For more information, visit www.nxera.life.



Read more at GlobeNewswire: Nxera Pharma Proposes Changes to its Board of Directors